Vaccine Against Canine Cancer Study is complete.

Calviri’s Vaccine Against Canine Cancer Study (VACCS), has finished the 5-year, 804 dog clinical trial.  The VACCS aimed at investigating a novel preventative cancer vaccine in dogs.  This trial leverages what is known about shared neoantigens.  Neoantigens are...